Try GOLD - Free

AI in currency

Business Standard

|

July 01, 2025

Artificial intelligence is quietly transforming consumer-facing industries. The first of a three-part series looks at how it is rewriting the rules of modern banking

- SHELLEY SINGH

AI in currency

Similarly, credit memos that once took bankers several days to prepare are now being auto-generated in minutes. AI reads financial documents, fetches data from APIs, and presents a risk summary that a human analyst then reviews and approves.

Pandharkar of EY India explains with an example: Suppose an auto ancillary company asks for a ₹12 crore inventory loan. They would need to analyze three years of profit and loss account, balance sheet, goods and services tax (GST) filing, bank statements, Udyog Aadhaar (for small businesses), credit scores, fraud checks, PAN verifications, and so on. Earlier, at least two analysts spent five working days putting this together. Now using GenAI, the system carries out the necessary checks, goes through 300 pages of source material, all in less than 10 minutes, and generates a five-page credit memo.

Banks are also deploying AI to read and interpret complex PDFs, summarize reports, and even conduct sentiment analysis of customer conversations.

"The real gain is in the time saved," says Pandharkar. "AI can read 300 pages in seconds. Humans can't compete with that—so the model becomes augmentation, not replacement."

Armed with intelligence provided by AI, human workload is reduced, shifting from the drudgery of going through multiple documents and several hundred pages, to, say, issuing loans or taking the final call. As Kanwar of Confluent India puts it: "We are moving from delayed intelligence to always-on intelligence."

In customer service functions, banks are deploying AI-powered voice bots that replace clunky IVRs. Instead of navigating phone menus, a customer simply says, "I need my tax certificate," and gets it.

MORE STORIES FROM Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size